72
Growth Score
pts
Heat Score
5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
352257
NomoCan Pharmaceuticals offers targeted therapies for some of the most aggressive cancers with unmet medical needs.
- Ehsan Sarafraz-Yazdi: CEO and Co-Founder
About the Company
NomoCan Pharmaceuticals offers targeted therapies for some of the most aggressive cancers with unmet medical needs. Its platform technology not only makes available a selective and specific diagnostic and prognostic test for early detection but more remarkably, it introduces highly effective monoclonal antibody (mAb) drugs for the treatment of
various cancers in order to “Bring Hope” to patients affected by this devastating disease.
The company is based in New York, New York.
